Martin-Luther-Universität Halle-Wittenberg

Kontakt für die Medien

Manuela Bank-Zillmann
Telefon: +49 345 55-21004

Ansprechpartner*in zu dieser Pressemitteilung

Professor Hermann H. Swalve
Institute of Agricultural and Nutritional Sciences
Telefon: +49 345 55-22320


Manuela Bank-Zillmann

Telefon: +49 345 55-21004
Telefax: +49 345 55-27404

Universitätsplatz 8/9
06108 Halle


Login für Redakteure

The claw disease tyloma is primarily genetic in cows

Nummer 005/2020 vom 09. Januar 2020
Scientists at Martin Luther University Halle-Wittenberg (MLU) and Georg August University Göttingen have succeeded in proving that a claw disease in cows is primarily genetic. Until now, the occurrence of interdigital hyperplasia has mostly been attributed to poor hygiene conditions in the barn. However, a team led by Professor Hermann Swalve discovered a farm in which the disease occurred frequently and was able to identify the gene responsible. As a result, the disease may now be contained through selective breeding.

"We rarely see such a case where everything fits perfectly together," says Hermann Swalve, Professor of Animal Breeding at the Institute for Agricultural and Nutritional Sciences at MLU. Many factors have to fit in order to find a single gene that is primarily responsible for a disease. Swalve’s team, whose findings have now been published in the journal "Frontiers in Genetics", succeeded in making the discovery because his research group had been working for years with large cow databases in Germany. In the course of their work, they came across a farm in which interdigital hyperplasia, also known as limax or tyloma, frequently occurred. Three to eight percent of all cows in Germany suffer from the disease at some stage in their lives, however it mostly affects older cows. A further, "stunted" claw emerges between the two claws of the hoof, spreading apart the real claws. "This results in tears to the skin, which in turn provide openings for bacteria and other infectious agents," says Swalve. The animals become lame and their lifespans are shortened.

"We previously carried out studies on the genetics of the disease, but we didn’t have enough affected animals at our disposal, so it was difficult to obtain statistical certainty," explains Swalve. It was therefore a stroke of luck to find a farm in north-western Germany where almost 60 per cent of the animals were affected by it. In a genome-wide association study, they compared 45,000 small DNA segments, so-called SNPs, from healthy and sick cows. Initially, they identified two sites that could be related to the disease. One was the gene for tyrosine kinase receptor 2 (ROR2). "Next we compared our results with medical studies on humans and found that this gene also plays a role in the development of human limbs," says Swalve. The team from the University of Göttingen, led by Professor Bertram Brenig, subsequently provided proof that the ROR2 gene actually is involved with the development of the disease. His research group sequenced the entire gene segment and found that a mutation leads to the exchange of an amino acid in the affected cows. In further experiments, Brenig was also able to prove that the defect actually leads to an alteration in protein concentration. "Once we were able to show that the mutation influences gene expression, we were able to conclusively explain how it is connected to the disease," said Brenig.

Swalve is surprised that the genetic background of the disease had been ignored for so long - even though, as early as 1952, Richard Götze, an internationally acclaimed veterinarian from Hanover, suspected that interdigital hyperplasia was almost exclusively genetic. This discovery did not find its way into animal breeding. Only now, with this new study, has Götze’s assumption been confirmed. The disease can now be tackled through selective breeding.


About the study: Zhang et al. Interdigital Hyperplasia in Holstein cattle is associated with a missense mutation in the signal peptide region of the Tyrosine-protein kinase transmembrane receptor gene. Frontiers in Genetics (2019). doi: 10.3389/fgene.2019.01157


Zum Seitenanfang